Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| BIONTECH | 7 | 13 | -0,26 % | ||
| INCYTE | 6 | 25 | -0,57 % | ||
| NEUMORA THERAPEUTICS | 6 | 1 | +0,40 % | ||
| NEUROCRINE BIOSCIENCES | 5 | 17 | -1,96 % | ||
| ALKERMES | 5 | 8 | +1,15 % | ||
| GILEAD SCIENCES | 5 | 5 | -0,09 % | ||
| INTELLIA THERAPEUTICS | 5 | 5 | -1,55 % | ||
| RHYTHM PHARMACEUTICALS | 5 | 3 | -0,65 % | ||
| MIRUM PHARMACEUTICALS | 5 | 1 | +0,11 % | ||
| NURIX THERAPEUTICS | 4 | 4 | -0,06 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Regulatory Milestone Boosts Gilead's Presence in Liver Disease Care | 6 | Insider Monkey | ||
| Mo | Gilead weekly Yeztugo HIV pill sNDA accepted by FDA | 2 | Seeking Alpha | ||
| Mo | MESOBLAST LIMITED: Becoming a substantial holder | 4 | ASX | ||
| Mo | FDA accepts Gilead application for once-weekly oral HIV prevention pill | 4 | Investing.com | ||
| Mo | Enliven Therapeutics closes $460M public offering | 1 | Investing.com | ||
| Mo | FDA nimmt Zulassungsantrag von Gilead für wöchentliche HIV-Präventionspille an | 15 | Investing.com Deutsch | ||
| Mo | Enliven Therapeutics schließt Kapitalerhöhung über 460 Mio. US-Dollar ab | 2 | Investing.com Deutsch | ||
| Mo | Adaptive Biotechnologies Aktie fällt nach Ankündigung einer Wandelanleihe | 3 | Investing.com Deutsch | ||
| Mo | Coherus Oncology, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| Mo | MeiraGTx Holdings plc - 8-K, Current Report | 1 | SEC Filings | ||
| Mo | Viatris Inc - 8-K, Current Report | 4 | SEC Filings | ||
| Mo | uniQure N.V. - 8-K, Current Report | 2 | SEC Filings | ||
| Mo | Neurocrine presents long-term data on Prader-Willi drug | 2 | Investing.com | ||
| Mo | Adaptive Biotechnologies plans to separate MRD, Immune Medicine units | 1 | Investing.com | ||
| Mo | Alvotech initiates $125M fundraising via public and private offering for biosimilar growth | 6 | Seeking Alpha | ||
| Mo | Pyxis Oncology, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| Mo | Neurocrine legt Daten zu Crenessity bei seltener CAH-Unterform vor | 1 | Investing.com Deutsch | ||
| Mo | Adaptive Biotechnologies Corporation Announces Proposed Convertible Senior Notes Offering | 2 | GlobeNewswire (USA) | ||
| Mo | Adaptive Biotechnologies Announces Plan to Separate Its MRD and Immune Medicine Businesses | 2 | GlobeNewswire (USA) | ||
| Mo | RHYTHM PHARMACEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.